DRAGARWQBSEDr Agarwals Eye Hospital Ltd-$LowNeutral
Announced Thu, 25 Sept · 18:37 IST

31st Annual General Meeting (AGM) - Results of Remote e-voting and E-voting at the AGM along with the Scrutinizer''s Report is enclosed.

Board & Shareholder Meetings View source PDF

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Dr. Agarwal's Eye Hospital held its 31st AGM on September 24, 2025, where shareholders voted on nine resolutions via remote e-voting and AGM e-voting. Of the 47,00,000 total equity shares, about 38,25,000 shares (~81.4%) were polled and all nine resolutions were passed. Key approvals included FY25 audited financial statements, a dividend of Rs. 3.50 per share (35%), appointment of statutory and secretarial auditors, ratification of the cost auditor's Rs. 90,000 remuneration, and reappointment of Dr. Amar Agarwal as Chairman & Managing Director and Dr. Athiya Agarwal as Whole-Time Director with revised remuneration. A special resolution to issue 1,32,827 equity shares on a preferential basis was also passed, but with notably lower support of 90.03% versus ~97.35% on other resolutions, as institutional and public non-institutional shareholders voted against it.

Likely market impact

Eligible shareholders will receive the Rs. 3.50 per share dividend, while the approved preferential allotment of 1,32,827 shares may lead to some equity dilution. The visible dissent (~10% against) on the preferential issue could draw investor attention to governance and related-party considerations.